Fate Therapeutics, Inc. (FATE)

1.46 +0.06 (+4.29%) USD  |  NASDAQ  |  Feb 20, 16:00
1.45 -0.01 (-0.68%) After-Hours: 20:00
More

Fate Therapeutics EBITDA (Quarterly YoY Growth)

EBITDA (Quarterly YoY Growth) Chart

View EBITDA (Quarterly YoY Growth) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly YoY Growth) Range, Past 5 Years

View EBITDA (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly YoY Growth) Benchmarks

View EBITDA (Quarterly YoY Growth) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade